Titan Medical Granted Patent Related to Instrument End-Effector for Use in Robotic Surgery

TORONTO, Feb. 27, 2018 (GLOBE NEWSWIRE)  Titan Medical Inc. (“Titan” or the “Company”) (TSX:TMD) (OTCQB:TITXF), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), has been granted Canadian Patent No. CA 2,982,615, titled “End Effector Apparatus for a Surgical Instrument.” This patent is related generally to a novel end-effector actuation mechanism, especially suitable for small instruments, such as those used in laparoscopic and robotic surgery. A corresponding The post Titan Medical Granted Patent Related to Instrument End-Effector for Use in Robotic Surgery appeared first on Public Wire.
http://bit.ly/2CMMkzD